Literature DB >> 12827358

The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine.

Lee E Eiden1, Martin K-H Schäfer, Eberhard Weihe, Burkhard Schütz.   

Abstract

The vesicular amine transporters (VATs) are expressed as integral proteins of the lipid bilayer membrane of secretory vesicles in neuronal and endocrine cells. Their function is to allow the transport of acetylcholine (by the vesicular acetylcholine transporter VAChT; SLC18A3) and biogenic amines (by the vesicular monoamine transporters VMAT1 and VMAT2; SLC18A1 and SLC18A2) into secretory vesicles, which then discharge them into the extracellular space by exocytosis. Transport of positively charged amines by members of the SLC18 family in all cases utilizes an electrochemical gradient across the vesicular membrane established by proton pumping into the vesicle via a vacuolar ATPase; the amine is accumulated in the vesicle at the expense of the proton gradient, at a ratio of one translocated amine per two translocated protons. The members of the SLC18 family have become important histochemical markers for chemical coding in neuroendocrine tissues and cells. The structural basis of their remarkable ability to transport positively charged amines against a very large concentration gradient, as well as potential disease association with impaired transporter function and expression, are under intense investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827358     DOI: 10.1007/s00424-003-1100-5

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  43 in total

1.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Identification of human vesicle monoamine transporter (VMAT2) lumenal cysteines that form an intramolecular disulfide bond.

Authors:  David S Thiriot; Michael K Sievert; Arnold E Ruoho
Journal:  Biochemistry       Date:  2002-05-21       Impact factor: 3.162

Review 3.  Vesicular neurotransmitter transporters: from bacteria to humans.

Authors:  S Schuldiner; A Shirvan; M Linial
Journal:  Physiol Rev       Date:  1995-04       Impact factor: 37.312

Review 4.  From bacterial antibiotic resistance to neurotransmitter uptake. A common theme of cell survival.

Authors:  S Schuldiner; A Shirvan; Y Stern-Bach; S Steiner-Mordoch; R Yelin; O Laskar
Journal:  Ann N Y Acad Sci       Date:  1994-09-15       Impact factor: 5.691

5.  Immunoaffinity purification of human choline acetyltransferase: comparison of the brain and placental enzymes.

Authors:  G Bruce; B H Wainer; L B Hersh
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

6.  Tyrosine hydroxylase-expressing and/or aromatic L-amino acid decarboxylase-expressing neurons in the mediobasal hypothalamus of perinatal rats: differentiation and sexual dimorphism.

Authors:  I S Balan; M V Ugrumov; A Calas; P Mailly; M Krieger; J Thibault
Journal:  J Comp Neurol       Date:  2000-09-18       Impact factor: 3.215

7.  Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

Authors:  Y M Wang; R R Gainetdinov; F Fumagalli; F Xu; S R Jones; C B Bock; G W Miller; R M Wightman; M G Caron
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

8.  Transient developmental expression of monoamine transporters in the rodent forebrain.

Authors:  C Lebrand; O Cases; R Wehrlé; R D Blakely; R H Edwards; P Gaspar
Journal:  J Comp Neurol       Date:  1998-11-30       Impact factor: 3.215

9.  The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter.

Authors:  A Alfonso; K Grundahl; J S Duerr; H P Han; J B Rand
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

10.  Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.

Authors:  E Weihe; M K Schäfer; J D Erickson; L E Eiden
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

View more
  68 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.

Authors:  Hakeem O Lawal; Hui-Yun Chang; Ashley N Terrell; Elizabeth S Brooks; Dianne Pulido; Anne F Simon; David E Krantz
Journal:  Neurobiol Dis       Date:  2010-05-26       Impact factor: 5.996

Review 3.  Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Maria Nguyen; Yvette C Wong; Daniel Ysselstein; Alex Severino; Dimitri Krainc
Journal:  Trends Neurosci       Date:  2018-11-30       Impact factor: 13.837

4.  Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules.

Authors:  K M Georgas; H S Chiu; E Lesieur; B A Rumballe; Melissa H Little
Journal:  Dev Dyn       Date:  2011-04-12       Impact factor: 3.780

Review 5.  Multifaceted role of heat shock protein 70 in neurons.

Authors:  Tom Z Lu; Yi Quan; Zhong-Ping Feng
Journal:  Mol Neurobiol       Date:  2010-04-01       Impact factor: 5.590

6.  A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo.

Authors:  Anna Grygoruk; Hao Fei; Richard W Daniels; Bradley R Miller; Aaron Diantonio; David E Krantz
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

7.  C6ORF192 forms a unique evolutionary branch among solute carriers (SLC16, SLC17, and SLC18) and is abundantly expressed in several brain regions.

Authors:  Josefin A Jacobsson; Olga Stephansson; Robert Fredriksson
Journal:  J Mol Neurosci       Date:  2009-08-21       Impact factor: 3.444

8.  Selective accumulation of biotin in arterial chemoreceptors: requirement for carotid body exocytotic dopamine secretion.

Authors:  Patricia Ortega-Sáenz; David Macías; Konstantin L Levitsky; José A Rodríguez-Gómez; Patricia González-Rodríguez; Victoria Bonilla-Henao; Ignacio Arias-Mayenco; José López-Barneo
Journal:  J Physiol       Date:  2016-10-09       Impact factor: 5.182

9.  AAH2 gene is not required for dopamine-dependent neurochemical and behavioral abnormalities produced by Toxoplasma infection in mouse.

Authors:  Ross McFarland; Zi Teng Wang; Yan Jouroukhin; Ye Li; Olga Mychko; Isabelle Coppens; Jianchun Xiao; Lorraine Jones-Brando; Robert H Yolken; L David Sibley; Mikhail V Pletnikov
Journal:  Behav Brain Res       Date:  2018-03-16       Impact factor: 3.332

10.  Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Authors:  Dana Yaffe; Sebastian Radestock; Yonatan Shuster; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.